160 related articles for article (PubMed ID: 12867727)
1. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
[TBL] [Abstract][Full Text] [Related]
2. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
3. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
Muhamuda K; Madhusudana SN; Ravi V
Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
[TBL] [Abstract][Full Text] [Related]
5. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
6. Possibility of Immediate Introduction of a Single-Dose Antibody Induction Test as a Refinement of the NIH Test for Inactivated Rabies Vaccine Potency Determination.
Stankov S; Obradović N; Vujin D; Vranješ N
Viral Immunol; 2020 Jun; 33(5):367-377. PubMed ID: 32159457
[TBL] [Abstract][Full Text] [Related]
7. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing.
Rooijakkers EJ; Uittenbogaard JP; Groen J; Osterhaus AD
J Virol Methods; 1996 Apr; 58(1-2):111-9. PubMed ID: 8783156
[TBL] [Abstract][Full Text] [Related]
8. [Testing for immunogenic and protective properties of vaccine against tissue-inactivated rabies].
Vrzal V; Cupera Z; Chumela J; Zatloukal L
Vet Med (Praha); 1990 Feb; 35(2):87-95. PubMed ID: 2353410
[TBL] [Abstract][Full Text] [Related]
9. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
10. Immune response to Japanese rabies vaccine in domestic dogs.
Shimazaki Y; Inoue S; Takahashi C; Gamoh K; Etoh M; Kamiyama T; Makie H
J Vet Med B Infect Dis Vet Public Health; 2003 Mar; 50(2):95-8. PubMed ID: 12675902
[TBL] [Abstract][Full Text] [Related]
11. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
12. In vitro potency tests: challenges encountered during method development.
Yomayuza CL; Thiel HJ; König M
Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody response in dogs and cats inoculated with commercial inactivated rabies vaccines.
Shiraishi R; Nishimura M; Nakashima R; Enta C; Hirayama N
J Vet Med Sci; 2014 Apr; 76(4):605-9. PubMed ID: 24389741
[TBL] [Abstract][Full Text] [Related]
14. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
Jallet C; Tordo N
J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
[TBL] [Abstract][Full Text] [Related]
15. Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA.
Toinon A; Moreno N; Chausse H; Mas E; Nicolai MC; Guinchard F; Jaudinaud I; Guinet-Morlot F; Riou P; Manin C
Biologicals; 2019 Jul; 60():49-54. PubMed ID: 31105021
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of inactivated tissue culture rabies vaccine in dogs.
Strating A; Bunn TO; Goff MT; Phillips CE
J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
[TBL] [Abstract][Full Text] [Related]
18. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
[TBL] [Abstract][Full Text] [Related]
19. An ELISA suitable for the detection of rabies virus antibodies in serum samples from human vaccinated with either cell-culture vaccine or suckling-mouse-brain vaccine.
Piza AS; Santos JL; Chaves LB; Zanetti CR
Rev Inst Med Trop Sao Paulo; 1999; 41(1):39-43. PubMed ID: 10436669
[TBL] [Abstract][Full Text] [Related]
20. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs.
Sugiyama M; Yoshiki R; Tatsuno Y; Hiraga S; Itoh O; Gamoh K; Minamoto N
Clin Diagn Lab Immunol; 1997 Nov; 4(6):727-30. PubMed ID: 9384298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
